Antipsychotic Drugs & Lithium Flashcards
Chlorpromazine
Phenothiazine
Phenothiazines
Chlorpromazine
Fluphenazine
Thioridazine
Fluphenazine
Phenothiazine
Thioridazine
Phenothiazine
Chlorpromazine
Fluphenazine
Thioridazine
(Phenothiazines)
Mechanism of action
Blockade of D2 receptors»_space; 5-HT2A receptors
Blockade of D2 receptors»_space; 5-HT2A receptors
Chlorpromazine, Fluphenazine, Thioridazine, (Phenothiazines)
Thiothixene, (Thioxanthene)
Haloperidol, (Butyrophenone)
Mechanism of action
Chlorpromazine
Fluphenazine
Thioridazine
(Phenothiazines)
Effects
a-Receptor blockade Muscarinic (M)-receptor blockade H1-receptor blockade CNS depression (sedation) Decreased seizure threshold QT prolongation
a-Receptor blockade Muscarinic (M)-receptor blockade H1-receptor blockade CNS depression (sedation) Decreased seizure threshold QT prolongation
Chlorpromazine Fluphenazine Thioridazine (Phenothiazines) Thiothixene Effects
Chlorpromazine Fluphenazine Thioridazine (Phenothiazines) Thiothixene Clinical applications
PSYCHIATRIC: schizophrenia (alleviate positive symptoms), bipolar disorder (manic phase) NONPSYCHIATRIC: antiemesis, preoperative sedation (promethazine), pruritus
PSYCHIATRIC: schizophrenia (alleviate positive symptoms), bipolar disorder (manic phase) NONPSYCHIATRIC: antiemesis, preoperative sedation (promethazine), pruritus
Chlorpromazine
Fluphenazine
Thioridazine
(Phenothiazines)
Clinical applications
Chlorpromazine Fluphenazine Thioridazine (Phenothiazines) Thiothixene Pharmacokinetics, Toxicities, Interactions
Oral and parenteral forms, long half-lifes with metabolism-dependent elimination, TOXICITY: extensions of effects on Alpha and M- receptors, blockade of dopamine receptors may result in akathisia, dystonia, parkinsonian symptoms, tardive dyskinesia, and hyperprolactinemia
Oral and parenteral forms, long half-lifes with metabolism-dependent elimination, TOXICITY: extensions of effects on Alpha and M- receptors, blockade of dopamine receptors may result in akathisia, dystonia, parkinsonian symptoms, tardive dyskinesia, and hyperprolactinemia
Chlorpromazine
Fluphenazine
Thioridazine
(Phenothiazines)
Pharmacokinetics, Toxicities, Interactions
Thiothixene
Thioxanthene
Thioxanthene
Thiothixene
Thiothixene
Mechanism of action
Blockade of D2 receptors»_space; 5-HT2A receptors
Thiothixene
Effects
a-Receptor blockade Muscarinic (M)-receptor blockade H1-receptor blockade CNS depression (sedation) Decreased seizure threshold QT prolongation
Thiothixene
Clinical applications
PSYCHIATRIC: schizophrenia (alleviate positive symptoms), bipolar disorder (manic phase) NONPSYCHIATRIC: antiemesis, preoperative sedation (promethazine), pruritus
Thiothixene
Pharmacokinetics, Toxicities, Interactions
Oral and parenteral forms, long half-lifes with metabolism-dependent elimination, TOXICITY: extensions of effects on Alpha and M- receptors, blockade of dopamine receptors may result in akathisia, dystonia, parkinsonian symptoms, tardive dyskinesia, and hyperprolactinemia
Butyrophenone
Haloperidol
Haloperidol
Butyrophenone
Haloperidol
Mechanism of action
Blockade of D2 receptors»_space; 5-HT2A receptors
Haloperidol
Effects
Some Alpha blockade, but minimal M-receptor blockade and much less sedation than the phenothiazines
Some Alpha blockade, but minimal M-receptor blockade and much less sedation than the phenothiazines
Haloperidol
Effects
Haloperidol
Clinical applications
Schizophrenia (alleviate positive symptoms), bipolar disorder (manic phase), Huntington’s chorea, Tourette’s syndrome
Schizophrenia (alleviate positive symptoms), bipolar disorder (manic phase), Huntington’s chorea, Tourette’s syndrome
Haloperidol
Clinical applications
Haloperidol
Pharmacokinetics, Toxicities, Interactions
Oral and parenteral forms with metabolism-dependent elimination, TOXICITY: extrapyramidal dysfunction is a major adverse effect
Oral and parenteral forms with metabolism-dependent elimination, TOXICITY: extrapyramidal dysfunction is a major adverse effect
Haloperidol
Pharmacokinetics, Toxicities, Interactions
Atypical antipsychotics
Aripiprazole Clozapine Olanzapine Quetiapine Risperidone Ziprasidone
Aripiprazole
Atypical antipsychotic
Clozapine
Atypical antipsychotic
Olanzapine
Atypical antipsychotic
Quetiapine
Atypical antipsychotic
Risperidone
Atypical antipsychotic
Risperidone
Atypical antipsychotic
Blockade of 5-HT2A receptors > blockade of D2 receptors
Aripiprazole
Clozaine
Risperidone
(atypical antipsychotic)
Mechanism of action
Aripiprazole
Clozaine
Risperidone
(atypical antipsychotic)
Mechanism of action
Blockade of 5-HT2A receptors > blockade of D2 receptors
Aripiprazole
Clozaine
Risperidone
(atypical antipsychotic)
Clinical applications
Schizophrenia- improve both positive and negative symptoms, bipolar disorder (olanzapine or risperidone adjunctive with lithium), agitation in Alzheimer’s and Parkinson’s patients (low doses), major depression (aripiprazole)
Schizophrenia- improve both positive and negative symptoms, bipolar disorder (olanzapine or risperidone adjunctive with lithium), agitation in Alzheimer’s and Parkinson’s patients (low doses), major depression (aripiprazole)
Aripiprazole
Clozaine
Risperidone
(atypical antipsychotic)
Clinical applications